Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$6.67 - $9.71 $14,914 - $21,711
-2,236 Reduced 98.68%
30 $0
Q2 2023

Aug 11, 2023

BUY
$6.86 - $10.86 $15,338 - $24,282
2,236 Added 7453.33%
2,266 $20,000
Q4 2022

Feb 02, 2023

SELL
$5.72 - $9.78 $223 - $381
-39 Reduced 56.52%
30 $0
Q3 2022

Nov 07, 2022

BUY
$7.24 - $10.31 $499 - $711
69 New
69 $1,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0

About POINT Biopharma Global Inc.


  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.